MarketInOut Stock Screener Log In | Sign Up

Orthocell Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 16:10
Orthocell Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization147.09 mln
Float229 mln
Earnings Date02/19/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.1
Caution advised

1-Year Forecast

0.90
Transformational upside

Relative Strength

6 / 100
Severely lagging

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-121%
Severely loss-making

Business Description

Orthocell Limited is an Australian medical company founded in 2006 and based in Murdoch that creates treatments to help the body repair damaged bones, joints, and soft tissues. Its current products include a knee and ankle cartilage cell therapy, a collagen membrane for dental bone regeneration, and a collagen-based scaffold for peripheral nerve repair. The company is also working on additional collagen-based products to treat nerve, tendon, and ligament injuries, as well as a cell therapy targeting common shoulder and elbow conditions. Orthocell sells its products both in Australia and in international markets.

Key Fundamentals

EPS-0.05
ROE-45.98
RPS0.04
ROIC-191
ROA-27.66
EBITDA, mln-12.43
EV / EBITDA-8.30
EV / EBIT-7.46
Revenue, mln11.41
EV / Revenue9.04

Quote Details

Last 0.535
Change -0.005 (-0.93%)
Open 0.54
Volume 165,019
Turnover 88,285
Average Volume 594,209

Financial Ratios

Pre-Tax Profit Margin-121
Leverage Ratio1.59
Current Ratio5.97
Price / Book4.29
Price / Tangible Book4.50
Debt / Equity0.05
Price / Sales12.27

Financial Strength

Altman Z-Score2.32
Piotroski F-Score 5 / 9
Beneish M-Score-2.1
1-Year Target Price0.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.9% 75 / 100   
1 Month -30.07% 6 / 100   
2 Months -24.65% 17 / 100   
6 Months -37.43% 19 / 100   
1 Year -54.08% 15 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog